LYR-210 Depot (LYR-210) for Adult Subjects With Chronic Sinusitis (LANTERN Study)

PHASE2CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

May 9, 2019

Primary Completion Date

March 25, 2020

Study Completion Date

February 4, 2021

Conditions
Chronic SinusitisChronic Rhinosinusitis (Diagnosis)
Interventions
DRUG

LYR-210

A single administration of LYR-210 depot

OTHER

Sham comparator

Sham comparator

Trial Locations (22)

2025

Middlemore Clinical Trials, Papatoetoe

2077

The ENT Centre, Hornsby

2145

Westmead Hospital, Westmead

3168

Monash Health, Clayton

3206

Clinical Trials New Zealand, Hamilton

6021

P3 Research Wellington, Wellington

Wellington Hospital, Wellington

8013

Southern Clinical Trials Ltd, Christchurch

Unknown

Royal Brisbane and Woman's Hospital, Brisbane

University Hospital for Otorhinolaryngology, Medical University of Graz, Vienna

Fakultni Nemocnice Brno OR, Brno

St Anne's Faculty Hospital, Brno

Provita Sp. z o.o. Centrum Medyczne Angelius Provita, Katowice

Centrum Medyczne All-Med, Krakow

Centrum Medyczne Plejady, Krakow

Centrum Medyczne PROMED, Krakow

Centrum Zdrowia MDM, Warsaw

Vistamed Sp. z o.o., Wroclaw

305 99

Fakultní nemocnice Plzeň, Pilsen

500 05

Fakultni Nemocnice Hradec Kralove Klinika otorinolaryngologie a chirurgie hlavy a krku, Hradec Králové

0626

Southern Clinical Trials Waitemata, Auckland

BOP 3110

P3 Research Tauranga, Tauranga

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Lyra Therapeutics

INDUSTRY